Literature DB >> 15497817

A comparison between in vitro rat and human and in vivo rat skin absorption studies.

B van Ravenzwaay1, E Leibold.   

Abstract

In vitro skin penetration rates in rat and man were compared to those obtained in vivo in rats. Saturation of absorption was frequently observed at higher exposure levels in in vitro and in vivo. Lipophilic compounds showed the highest penetration rates through rat skin in vitro. In all cases in vitro dermal penetration through rat skin was higher than in vivo. Thus, the in vitro study may serve as a first tier test. The in vivo data suggest an inverse relationship between molecular weight and the rate of dermal absorption for lipophilic as well as hydrophilic compounds. Rat skin was more permeable to all tested substances than human skin (mean difference 10.9-fold). Thus, the systemic exposure of humans may be significantly overestimated if risk assessment is based only on the results of an in vivo rat study, because human skin is less permeable than rat skin. It would appear, therefore, that an estimate of actual dermal penetration through human skin should be based on the combined use of in vivo and in vitro data, using the following equation: % Human dermal penetration = (% rat in vivo dermal penetration) x (in vitro rate dermal penetration human / in vitro rate dermal penetration rat).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15497817     DOI: 10.1191/0960327104ht471oa

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  19 in total

1.  Essential oil from Zanthoxylum bungeanum Maxim. and its main components used as transdermal penetration enhancers: a comparative study.

Authors:  Yi Lan; Hui Li; Yan-yan Chen; Ye-wen Zhang; Na Liu; Qing Zhang; Qing Wu
Journal:  J Zhejiang Univ Sci B       Date:  2014-11       Impact factor: 3.066

Review 2.  Human skin models: From healthy to disease-mimetic systems; characteristics and applications.

Authors:  Tânia Moniz; Sofia A Costa Lima; Salette Reis
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

3.  Estimation of human percutaneous bioavailability for two novel brominated flame retardants, 2-ethylhexyl 2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl) tetrabromophthalate (BEH-TEBP).

Authors:  Gabriel A Knudsen; Michael F Hughes; J Michael Sanders; Samantha M Hall; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-11       Impact factor: 4.219

4.  2,4,6-Tribromophenol Disposition and Kinetics in Rodents: Effects of Dose, Route, Sex, and Species.

Authors:  Gabriel A Knudsen; Andrew W Trexler; Alicia C Richards; Samantha M Hall; Michael F Hughes; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

5.  The biological fate of decabromodiphenyl ethane following oral, dermal or intravenous administration.

Authors:  Gabriel A Knudsen; J Michael Sanders; Michael F Hughes; Ethan P Hull; Linda S Birnbaum
Journal:  Xenobiotica       Date:  2016-10-28       Impact factor: 1.908

6.  Oral doxycycline prevents skin-associated adverse effects induced by injectable collagenase in a rodent model of capsular contracture around silicone implants.

Authors:  Yannick F Diehm; Dimitra Kotsougiani-Fischer; Elena Porst; Valentin Haug; Laura C Siegwart; Daniel Overhoff; Ulrich Kneser; Sebastian Fischer
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

7.  Estimation of tetrabromobisphenol A (TBBPA) percutaneous uptake in humans using the parallelogram method.

Authors:  Gabriel A Knudsen; Michael F Hughes; Katelyn L McIntosh; J Michael Sanders; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-24       Impact factor: 4.219

8.  Dermal disposition of Tetrabromobisphenol A Bis(2,3-dibromopropyl) ether (TBBPA-BDBPE) using rat and human skin.

Authors:  Gabriel A Knudsen; Michael F Hughes; Linda S Birnbaum
Journal:  Toxicol Lett       Date:  2018-11-24       Impact factor: 4.372

9.  Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.

Authors:  Sebastian Fischer; Christoph Hirche; Yannick Diehm; Kristo Nuutila; Jurij Kiefer; Emre Gazyakan; Ericka M Bueno; Thomas Kremer; Ulrich Kneser; Bohdan Pomahac
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

Review 10.  Skin models for the testing of transdermal drugs.

Authors:  Eman Abd; Shereen A Yousef; Michael N Pastore; Krishna Telaprolu; Yousuf H Mohammed; Sarika Namjoshi; Jeffrey E Grice; Michael S Roberts
Journal:  Clin Pharmacol       Date:  2016-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.